Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2026-06-12 16:11:03 ET · period of report 2026-06-11 · accession 0001104659-26-073459 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-12 16:11 | 2026-06-11 | NVCT | Sanchez Juan | Dir | A - Grant | $0.00 | +35.0K | 113.4K | +45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-11 | A | A | 35,000 | $0.00 | 113,380 | D | — | — | (F1) The 35,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Dr. Sanchez's continued service on the Company's Board of Directors on such dates. (F2) Includes 230 shares of restricted common stock that were inadvertently omitted from the initial holdings on Dr Sanchez's Form 3, filed on October 31, 2025. |